Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2019
Single-anastomosis duodenal ileostomy with sleeve is a safe and effective option for patients in an ambulatory surgical center.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cottam Samuel, Ng Peter, Sharp Lindsey, Medlin Walter, Cottam Daniel Rhead
Аннотация
BACKGROUND: The single-anastomosis duodenal ileostomy with sleeve gastrectomy (SADI-S) is gaining popularity in the United States as an alternative to the gastric bypass for patients with a high body mass index (BMI) or who are less likely to succeed with a sleeve. While SADI-S has similar weight loss to the gastric bypass, the complication rate is significantly lower, allowing surgeons to perform SADI-S in an ambulatory surgical center with a 23-hour stay.
OBJECTIVES: To determine if SADI-S can be safely performed in an ambulatory surgical setting.
SETTING: Private practice.
METHODS: All SADI-S procedures performed from August 2015 to March 2019 at 2 bariatric centers were included in this study. Patients selection for SADI-S in the ambulatory surgical center required no end organ damage, no evidence of severe sleep apnea, and BMI <55 for males and BMI <60 for females. All data were gathered retrospectively from prospectively kept databases. Thirty-day complication rates were analyzed using the Clavien-Dindo scale to assess the safety of performing SADI-S in an ambulatory surgical center.
RESULTS: Eighty-two patients were included in this study. The sample was 72% female with an average age of 46 and BMI of 45. All patients received planned intravenous fluid within 3 days after the procedure. There were 2 (2.4%) grade IIIb to V complications. There were no mortalities in this series.
CONCLUSION: SADI-S can be performed safely in an ambulatory surgery 23-hour setting with appropriate patient selection, perioperative support, and enhanced recovery after surgery protocols.
OBJECTIVES: To determine if SADI-S can be safely performed in an ambulatory surgical setting.
SETTING: Private practice.
METHODS: All SADI-S procedures performed from August 2015 to March 2019 at 2 bariatric centers were included in this study. Patients selection for SADI-S in the ambulatory surgical center required no end organ damage, no evidence of severe sleep apnea, and BMI <55 for males and BMI <60 for females. All data were gathered retrospectively from prospectively kept databases. Thirty-day complication rates were analyzed using the Clavien-Dindo scale to assess the safety of performing SADI-S in an ambulatory surgical center.
RESULTS: Eighty-two patients were included in this study. The sample was 72% female with an average age of 46 and BMI of 45. All patients received planned intravenous fluid within 3 days after the procedure. There were 2 (2.4%) grade IIIb to V complications. There were no mortalities in this series.
CONCLUSION: SADI-S can be performed safely in an ambulatory surgery 23-hour setting with appropriate patient selection, perioperative support, and enhanced recovery after surgery protocols.
Предметные рубрики MeSH
AdultAmbulatory Surgical ProceduresAnastomosis, SurgicalBody Mass IndexCombined Modality TherapyDatabases, FactualDuodenumFemaleGastrectomyHumansIleostomyMaleMiddle AgedObesity, MorbidPatient SafetyPostoperative ComplicationsRetrospective StudiesRisk AssessmentSafety ManagementTreatment OutcomeUnited States